Cefixime is an oral third-generation cephalosporin with excellent Gram-negative activity used for respiratory, urinary and gonococcal infections, and remains a WHO-recommended option for uncomplicated gonorrhoea. Simson Pharma's Cefixime reference standard and impurities support the high-volume compendial testing this widely prescribed generic cephalosporin demands.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cefixime Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.